xCures raises USD12.69m in Series A funding for AI-powered precision oncology platform
xCures Inc, a specialist in the patient-centric use of artificial intelligence (AI) and predictive modelling, has raised USD12.69 million in a Series A funding round led by Boehringer Ingelheim Venture Fund and joined by Vanedge Capital, Harmonix Fund, Metaplanet, as well as other investors. The funding will be used to